An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on a peptide forum asked whether they should increase their dose of BPC-157 (a peptide people discuss for healing) to treat a rotator cuff injury. They describe having used another peptide, TB-500, for two weeks at a high daily dose, then switching to BPC-157: first 250 micrograms a day for a week, now 500 micrograms a day and thinking about doing 500 twice a day. They say they’ve noticed some improvement starting around week three and want advice about bumping the dose. BPC-157 is a short string of amino acids (a peptide) that was originally found in stomach juice. In plain terms, it’s a small synthetic copy of a natural fragment that some researchers think can help tissues heal. It’s not a magic drug you can buy at a pharmacy for injuries; most of the writing about it comes from animal studies and anecdotal reports from people trying it themselves. It’s different from prescription drugs like Ozempic — it’s not approved for human medical use by major regulators. What the available evidence actually shows is thin. Most published studies are in animals (rats and mice), where BPC-157 sometimes speeds healing of tendons, muscles, and gut injuries. There are few if any robust clinical trials in humans. A single person’s report of modest improvement by week three is exactly that: an individual anecdote. It can’t tell us how effective the peptide is, what the optimal dose would be, or whether the improvement was due to the peptide, natural healing, physical therapy, or chance. There are no high-quality studies that prove doubling to 500 micrograms twice daily is safer or more effective. Why this matters is practical: people with lingering tendon or muscle injuries are desperate for faster relief and may experiment with unapproved substances. If something helps safely, it could shorten recovery time. But without solid human data, there’s no reliable dosing guide or predictable benefit. Physical therapy, proven rehabilitation methods, and discussions with a healthcare professional remain the safest paths. If someone is considering peptides, they should know they’re taking an experimental approach rather than following established medical recommendations. There are several caveats and risks. BPC-157 is not approved by major drug regulators, so quality and purity of “research” or online-sold vials can vary. Short- and long-term safety in humans aren’t well studied. Possible side effects are poorly characterized because formal trials are lacking. Combining multiple experimental peptides (like TB-500 plus BPC-157) increases unknown risks. People who are pregnant, nursing, have cancer, or are on other medications should be especially cautious. Always talk to a knowledgeable clinician before changing doses or adding unregulated substances, and consider relying on therapies with established safety and benefit first. Bottom line: anecdotal improvement is interesting but not proof; doubling an unapproved peptide dose is risky without better human evidence or medical guidance.
Source: r/Peptides